Physicians' Academy for Cardiovascular Education

Latest results with non-LDL lowering agents in reducing CV risk

10' education - Oct. 26, 2020 - Prof. Ulrich Laufs, MD - Leipzig, Germany

Video navigation menu

  • Residual CV risk – elevated triglycerides 02:04
  • Residual CV risk – elevated Lp(a) 05:07
  • Effects of omega-3 fatty acids on CV events 06:05
  • Results of the REDUCE-IT trial 09:18
  • Other CV outcome trials in patients with hypertriglyceridemia 16:21

Educational information

This lecture by prof. Ulrich Laufs, MD is part of the virtual symposium "Reducing Residual Risk for Cardiovascular Disease: Is there a role for non-LDL lowering agents?" from the German Cardiac Society.

Faculty

Prof. Ulrich Laufs, MD is professor of cardiology at the University of Leipzig Medical Center in Germany.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Amarin.

Share this page with your colleagues and friends: